Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Johan Steineger"'
Publikováno v:
Tidsskrift for Den norske legeforening.
Autor:
Anikka Michelsen, Thor Ueland, Sinan Dheyauldeen, Terje Osnes, Pål Aukrust, Ketil Heimdal, Johan Steineger
Publikováno v:
The Laryngoscope. 129:E44-E49
Objectives/hypothesis We aimed to investigate if vascular endothelial growth factor (VEGF) and other angiogenic and inflammatory factors correlated with the clinical presentation in hereditary hemorrhagic telangiectasia (HHT) patients, particularly i
Publikováno v:
The Laryngoscope. 128:2237-2244
Objectives/hypothesis Long-term follow-up of intranasal bevacizumab therapy in hereditary hemorrhagic telangiectasia (HHT). Study design Prospective, noncomparative study. Methods Patients treated for HHT-associated epistaxis by intranasal submucosal
Autor:
Else Merckoll, Sinan Dheyauldeen, Ketil Heimdal, John Magnar Slåstad, Johan Steineger, Erik Fink Eriksen
Publikováno v:
The Laryngoscope. 128:593-596
Intranasal bevacizumab injections have been used in treating hereditary hemorrhagic telangiectasia (HHT)-related epistaxis since 2009. It is believed to be a safe and effective treatment for a selected group of HHT patients in reducing frequency and
Publikováno v:
The Laryngoscope. 130
BACKGROUND Epistaxis is the most common symptom in patients with hereditary hemorrhagic telangiectasia (HHT), with the greatest negative impact on quality of life (QoL). Repeated intranasal submucosal bevacizumab injections (RISBI) is a relatively ne
Autor:
Johan, Steineger, Thor, Ueland, Pål, Aukrust, Anikka, Michelsen, Terje, Osnes, Ketil, Heimdal, Sinan, Dheyauldeen
Publikováno v:
The Laryngoscope. 129(1)
We aimed to investigate if vascular endothelial growth factor (VEGF) and other angiogenic and inflammatory factors correlated with the clinical presentation in hereditary hemorrhagic telangiectasia (HHT) patients, particularly in regard to the severi
Publikováno v:
The Laryngoscope. 128(10)
Long-term follow-up of intranasal bevacizumab therapy in hereditary hemorrhagic telangiectasia (HHT).Prospective, noncomparative study.Patients treated for HHT-associated epistaxis by intranasal submucosal bevacizumab injections between June 2011 and
Autor:
Johan Steineger, Kjell Brondbo
Publikováno v:
Otolaryngology.
Objective: We report a type of hypopharyngeal congenital malformation not previously described in the world literature. Case report: A slightly preterm, female newborn presented with stridor immediately after birth. Flexible laryngoscopy showed the p